Please provide your email address to receive an email when new articles are posted on . WASHINGTON — CD19 chimeric antigen receptor T-cell therapy led to remission, or ceased disease progression, over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback